Study.. Breakthrough in brain cancer treatment

An experimental oral drug significantly delayed the growth of a malignant brain tumor, a major breakthrough in treating brain cancers that have progressed poorly for decades and have a high rate of disability and early death.

showed study Patients with grade 2 gliomas who took vorazidenib from Servier Pharmaceuticals after surgery and before chemotherapy or radiation therapy reported significant improvement Sunday in the New England Journal of Medicine.

According to the study, the growth and development of cancer cells was twice as delayed compared to patients who did not take this drug.

By delaying tumor growth, the study showed the drug also extended the time patients, who are often healthy young adults, had to wait before starting chemotherapy and radiation.

Therefore, the study suggests that the drug may help delay cognitive decline, memory loss, and other side effects that can accompany metastatic brain cancer.

The drug, the study showed, acts as an inhibitor of two enzymes, IDH1 and IDH2, which show early activity in mutant IDH gliomas, and the drug penetrates the tumor site through the blood-brain barrier.

According to the study, gliomas are the most common malignant primary brain tumors in adults and are classified by the World Health Organization (WHO) into different tumor subtypes and tumor grades according to different histological and molecular features.

The study showed that IDH1 and IDH2 enzymes were present in almost all metastatic grade II gliomas in adults.

According to the study, more than 80 percent of grade II glioma patients have cancers with mutations in a gene called IDH that promotes tumor growth.

See also  UK gives green light to world-first CRISPR gene-editing therapy

The study shows that most drugs cannot cross the protective layer of vessels and tissues called the blood-brain barrier, and the small number of affected patients makes it difficult to conduct large trials.

In the trial, 331 patients with malignant grade II glioma had some residual tumor tissue or relapsed after surgery. Patients from 77 health centers in 10 countries participated.

About 168 patients took the drug as a daily pill, while about 163 patients took a placebo.

Patients who took the experimental drug had a median cancer-free survival of 28 months, compared with 11 months for patients who took a placebo.

Within two years, the probability of not needing additional treatment was about 83 percent for patients taking the drug, compared to 27 percent for patients taking the placebo.

To treat grade II gliomas, doctors typically surgically remove as much of the cancer as possible, the study indicates. Then they monitor the growth of the tumors or treat them with chemotherapy and radiation, but these tumors are incurable and sometimes come back after a few years.

  • Nadia Barnett

    "Award-winning beer geek. Extreme coffeeaholic. Introvert. Avid travel specialist. Hipster-friendly communicator."

    Related Posts

    • science
    • January 11, 2024
    • 596 views
    A “supermaterial” of carbon… science when the Chinese kill two birds with one stone

    Just type “carbon dioxide recycling” into a search engine for scientific research, “Google Scholar,” and you'll be greeted with dozens of success stories in which the heroes are researchers who…

    • science
    • January 10, 2024
    • 500 views
    The Future of Peace and Development in Yemen in Light of the Trap of Psychological Disorders (1) | Dr. Muhammad al-Maithami

    A husband sticks a cigarette in his wife's eyes. Inadequate shelter. She then commits suicide, and by doing so will provide them with comfort, peace and tranquility at home. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Best HydraFacial Clinic in Dubai: The Magic of Radiant Skin

    Best HydraFacial Clinic in Dubai: The Magic of Radiant Skin

    Free Job Posting Sites in the UAE: Perfect for Both Job Seekers and Recruiters

    Free Job Posting Sites in the UAE: Perfect for Both Job Seekers and Recruiters

    Yaroslav Bogdanov: Google in Dubai announced the launch of an artificial intelligence initiative for MENA countries

    Yaroslav Bogdanov: Google in Dubai announced the launch of an artificial intelligence initiative for MENA countries

    How to Choose the Right Mattress: Find the Best Fit for You

    How to Choose the Right Mattress: Find the Best Fit for You

    Emils Kerimovs on Wealthtech Revolution: Investing in the Middle East and Africa

    Emils Kerimovs on Wealthtech Revolution: Investing in the Middle East and Africa

    Forex Brokers Review: Is ITBFX A Safe Broker?

    Forex Brokers Review: Is ITBFX A Safe Broker?